The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Brigitte Fauroux, Eric A F Simões, Paul A Checchia, Bosco Paes, Josep Figueras-Aloy, Paolo Manzoni, Louis Bont, Xavier Carbonell-Estrany
Author Information
  1. Brigitte Fauroux: Necker University Hospital and Paris 5 University, Paris, France.
  2. Eric A F Simões: University of Colorado School of Medicine, and Center for Global Health, Colorado School of Public Health, Aurora, CO, USA.
  3. Paul A Checchia: Baylor College of Medicine, Texas Children's Hospital Houston, Houston, TX, USA.
  4. Bosco Paes: Department of Paediatrics (Neonatal Division), McMaster University, Hamilton, Canada.
  5. Josep Figueras-Aloy: Hospital Clínic, Catedràtic de Pediatria, Universitat de Barcelona, Barcelona, Spain.
  6. Paolo Manzoni: Sant'Anna Hospital, Turin, Italy.
  7. Louis Bont: University Medical Center Utrecht, Utrecht, The Netherlands.
  8. Xavier Carbonell-Estrany: Hospital Clinic, Institut d'Investigacions Biomediques August Pi Suñer (IDIBAPS), Barcelona, Spain. carbonell@comb.cat.

Abstract

INTRODUCTION: The REGAL (RSV Evidence-a Geographical Archive of the Literature) series provide a comprehensive review of the published evidence in the field of respiratory syncytial virus (RSV) in Western countries over the last 20 years. The objective of this fifth publication was to determine the long-term respiratory morbidity associated with RSV lower respiratory tract infection (RSV LRTI) in early life.
METHODS: A systematic review was undertaken for articles published between January 1, 1995 and December 31, 2015. This was supplemented by inclusion of papers published whilst drafting the manuscript. Studies reporting data on the incidence and long-term wheezing and asthma following RSV LRTI in early life were included. Study quality and strength of evidence (SOE) were graded using recognized criteria.
RESULTS: A total of 2337 studies were identified of which 74 were included. Prospective, epidemiologic studies consistently demonstrated that RSV LRTI is a significant risk factor for on-going respiratory morbidity characterized by transient early wheezing and recurrent wheezing and asthma within the first decade of life and possibly into adolescence and adulthood (high SOE). RSV LRTI was also associated with impaired lung function in these children (high SOE). Respiratory morbidity has been shown to result in reduced quality of life and increased healthcare resource use (moderate SOE). The mechanisms through which RSV contributes to wheezing/asthma development are not fully understood, but appear to relate to the viral injury, preexisting abnormal lung function and/or other factors that predispose to wheezing/asthma, including genetic susceptibility, altered immunology, eosinophilia, and associated risk factors such as exposure to environmental tobacco smoke (high SOE).
CONCLUSION: There is growing evidence that RSV LRTI in early childhood is associated with long-term wheezing and asthma and impaired lung function. Future research should aim to fully elucidate the pathophysiological mechanisms through which RSV causes recurrent wheezing/asthma.

Keywords

References

  1. Stud Health Technol Inform. 2006;124:809-14 [PMID: 17108613]
  2. J Allergy Clin Immunol. 2008 Oct;122(4):726-733.e3 [PMID: 18760461]
  3. Curr Opin Pediatr. 2013 Jun;25(3):344-9 [PMID: 23657245]
  4. Pediatrics. 2000 Jan;105(1 Pt 1):79-83 [PMID: 10617708]
  5. Pediatr Pulmonol. 2004 Aug;38(2):155-60 [PMID: 15211700]
  6. Pediatr Allergy Immunol. 2002 Dec;13(6):418-25 [PMID: 12485317]
  7. Ther Adv Infect Dis. 2013 Aug;1(4):139-50 [PMID: 25165549]
  8. Pediatr Allergy Immunol. 2005 Aug;16(5):386-92 [PMID: 16101930]
  9. J Allergy Clin Immunol. 2009 May;123(5):1055-61, 1061.e1 [PMID: 19361850]
  10. Epidemiol Infect. 2014 Jul;142(7):1362-74 [PMID: 24029023]
  11. Pediatrics. 2013 Aug;132(2):e341-8 [PMID: 23878043]
  12. Pediatrics. 2007 Oct;120(4):e1076-81 [PMID: 17908728]
  13. Respir Res. 2011 Sep 12;12:121 [PMID: 21910858]
  14. J Allergy Clin Immunol. 2007 May;119(5):1086-91 [PMID: 17313976]
  15. Pediatr Infect Dis J. 2010 Sep;29(9):872-4 [PMID: 20803817]
  16. Eur Ann Allergy Clin Immunol. 2005 Dec;37(10):392-6 [PMID: 16528903]
  17. J Allergy Clin Immunol. 2009 Jan;123(1):131-137.e1 [PMID: 19130934]
  18. Acta Paediatr. 2014 Aug;103(8):850-5 [PMID: 24766320]
  19. J Allergy Clin Immunol. 2013 Jul;132(1):227-9 [PMID: 23419541]
  20. Infect Dis Ther. 2016 Dec;5(4):453-471 [PMID: 27864751]
  21. Clin Ther. 2010 Dec;32(14):2422-32 [PMID: 21353110]
  22. Thorax. 2004 Jun;59(6):512-6 [PMID: 15170037]
  23. Pediatr Infect Dis J. 2010 Jan;29(1):39-42 [PMID: 19907362]
  24. Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1975-81 [PMID: 22240853]
  25. Clin Exp Allergy. 2004 May;34(5):801-3 [PMID: 15144474]
  26. Eur Respir J. 2012 Jan;39(1):76-80 [PMID: 21700604]
  27. Pediatr Res. 2011 Nov;70(5):518-23 [PMID: 21814157]
  28. Pediatr Pulmonol. 2013 Jul;48(7):633-9 [PMID: 23129516]
  29. Allergy. 2003 Sep;58(9):878-84 [PMID: 12911416]
  30. An Pediatr (Barc). 2004 Feb;60(2):117-24 [PMID: 14757014]
  31. Infect Dis Ther. 2016 Dec;5(4):417-452 [PMID: 27628014]
  32. Am J Respir Crit Care Med. 2005 Jan 15;171(2):137-41 [PMID: 15516534]
  33. Acta Paediatr. 2007 Oct;96(10):1464-9 [PMID: 17880415]
  34. BMC Pediatr. 2005 Aug 18;5:31 [PMID: 16109158]
  35. Am J Respir Crit Care Med. 2009 Jun 15;179(12):1091-7 [PMID: 19286626]
  36. Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S184-7, discussion S187-8 [PMID: 16378044]
  37. Eur Respir J. 2002 Nov;20(5):1277-83 [PMID: 12449185]
  38. An Esp Pediatr. 2001 Dec;55(6):511-6 [PMID: 11730611]
  39. Acta Paediatr. 2015 Jan;104(1):53-8 [PMID: 25169812]
  40. PLoS One. 2014 Feb 26;9(2):e89186 [PMID: 24586581]
  41. Arch Dis Child. 2009 Feb;94(2):99-103 [PMID: 18653625]
  42. Pediatr Infect Dis J. 2004 May;23(5):414-7 [PMID: 15131463]
  43. Pediatr Allergy Immunol. 2022 Oct;33(10):e13869 [PMID: 36282129]
  44. J Allergy Clin Immunol. 2009 Feb;123(2):398-403 [PMID: 19101023]
  45. Eur J Pediatr. 2014 Nov;173(11):1497-504 [PMID: 24898777]
  46. Pediatr Infect Dis J. 2001 Mar;20(3):277-82 [PMID: 11303830]
  47. PLoS One. 2015 Nov 20;10(11):e0142649 [PMID: 26587832]
  48. Pediatr Infect Dis J. 2015 Oct;34(10):1131-2 [PMID: 26132826]
  49. Lancet. 2010 May 1;375(9725):1545-55 [PMID: 20399493]
  50. Chest. 2010 Aug;138(2):338-44 [PMID: 20435661]
  51. Am J Respir Crit Care Med. 2000 May;161(5):1501-7 [PMID: 10806145]
  52. Arch Pediatr Adolesc Med. 2010 Oct;164(10):915-22 [PMID: 20921348]
  53. Eur Respir J. 2014 Sep;44(3):666-74 [PMID: 24993909]
  54. J Pediatr. 2014 Jul;165(1):123-128.e3 [PMID: 24725580]
  55. Lancet. 1999 Aug 14;354(9178):541-5 [PMID: 10470697]
  56. Allergy. 2009 Sep;64(9):1359-65 [PMID: 19416146]
  57. Am J Respir Crit Care Med. 2014 Aug 15;190(4):392-8 [PMID: 24927374]
  58. Acta Paediatr. 2016 Jul;105(7):834-41 [PMID: 26970427]
  59. Arch Dis Child. 2004 Jul;89(7):673-8 [PMID: 15210503]
  60. Infect Dis Ther. 2017 Mar;6(1):37-56 [PMID: 28070870]
  61. Pediatrics. 1995 Apr;95(4):500-5 [PMID: 7700748]
  62. Pediatr Allergy Immunol. 2009 Aug;20(5):471-6 [PMID: 19140903]
  63. PLoS One. 2015 May 08;10(5):e0125422 [PMID: 25955487]
  64. Pediatr Int. 2008 Feb;50(1):51-6 [PMID: 18279205]
  65. Pediatr Allergy Immunol. 1997 Feb;8(1):1-6 [PMID: 9260211]
  66. Pediatr Pulmonol. 2015 Apr;50(4):389-95 [PMID: 24668616]
  67. Infect Disord Drug Targets. 2012 Apr;12(2):92-7 [PMID: 22335498]
  68. Pediatr Pulmonol. 2001 Jun;31(6):419-24 [PMID: 11389573]
  69. Respir Med. 2006 May;100(5):878-83 [PMID: 16198099]
  70. Thorax. 2009 Jun;64(6):490-5 [PMID: 19213770]
  71. Am J Respir Crit Care Med. 2008 Oct 1;178(7):667-72 [PMID: 18565953]
  72. J Allergy Clin Immunol. 2012 Jul;130(1):91-100.e3 [PMID: 22444510]
  73. Thorax. 2010 Dec;65(12):1045-52 [PMID: 20581410]
  74. Am J Respir Crit Care Med. 2000 May;161(5):1518-23 [PMID: 10806148]
  75. N Engl J Med. 2009 Feb 5;360(6):588-98 [PMID: 19196675]
  76. Infect Dis Ther. 2016 Sep;5(3):271-98 [PMID: 27480325]
  77. BMC Pediatr. 2013 Jun 19;13:97 [PMID: 23782528]
  78. N Engl J Med. 2013 May 9;368(19):1791-9 [PMID: 23656644]
  79. Pediatr Allergy Immunol. 2000 Aug;11(3):193-7 [PMID: 10981530]
  80. PLoS One. 2014 Jan 31;9(1):e87162 [PMID: 24498037]
  81. Acta Paediatr. 2005 Feb;94(2):159-65 [PMID: 15981748]
  82. Acta Paediatr. 2005 Oct;94(10):1378-83 [PMID: 16263629]

Word Cloud

Created with Highcharts 10.0.0RSVrespiratoryLRTIwheezingSOEmorbidityassociatedearlylifefunctionRespiratorypublishedevidencelong-termasthmahighlungwheezing/asthmareviewtractinfectionincludedqualitystudiesriskrecurrentimpairedmechanismsfullyfactorsINTRODUCTION:REGALEvidence-aGeographicalArchiveLiteratureseriesprovidecomprehensivefieldsyncytialvirusWesterncountrieslast20 yearsobjectivefifthpublicationdeterminelowerMETHODS:systematicundertakenarticlesJanuary11995December312015supplementedinclusionpaperswhilstdraftingmanuscriptStudiesreportingdataincidencefollowingStudystrengthgradedusingrecognizedcriteriaRESULTS:total2337identified74Prospectiveepidemiologicconsistentlydemonstratedsignificantfactoron-goingcharacterizedtransientwithinfirstdecadepossiblyadolescenceadulthoodalsochildrenshownresultreducedincreasedhealthcareresourceusemoderatecontributesdevelopmentunderstoodappearrelateviralinjurypreexistingabnormaland/orpredisposeincludinggeneticsusceptibilityalteredimmunologyeosinophiliaexposureenvironmentaltobaccosmokeCONCLUSION:growingchildhoodFutureresearchaimelucidatepathophysiologicalcausesBurdenLong-termMorbidityAssociatedSyncytialVirusInfectionEarlyChildhoodAsthmaBronchialhyperreactivityBronchiolitisLowerLungRecurrentSensitizationWheezing

Similar Articles

Cited By